Dr. Ryan Lang, M.D

NPI: 1366785818
Total Payments
$443,150
2022 Payments
$204,238
Companies
1
Transactions
33

Payment Breakdown by Category

Consulting$442,970 (100.0%)
Food & Beverage$180.54 (0.0%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $442,970 31 100.0%
Food and Beverage $180.54 2 0.0%

Top Paying Companies

Company Total Records Latest Year
Otsuka Pharmaceutical Development & Commercialization, Inc. $443,150 33 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2022 $204,238 14 Otsuka Pharmaceutical Development & Commercialization, Inc. ($204,238)
2021 $167,428 14 Otsuka Pharmaceutical Development & Commercialization, Inc. ($167,428)
2020 $71,484 5 Otsuka Pharmaceutical Development & Commercialization, Inc. ($71,484)

All Payment Transactions

33 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/15/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $11,574.00 General
12/12/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $19,290.00 General
11/03/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $15,432.00 General
09/27/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $15,432.00 General
09/08/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $15,432.00 General
09/08/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $3,630.80 General
08/04/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $14,523.20 General
07/11/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $18,154.00 General
06/06/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $14,523.20 General
05/06/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $14,523.20 General
04/05/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $18,154.00 General
04/05/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $14,523.20 General
02/07/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $14,523.20 General
01/10/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $14,523.20 General
12/09/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $18,154.00 General
11/08/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $14,523.20 General
10/06/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $18,154.00 General
10/01/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. Food and Beverage In-kind items and services $26.25 General
09/16/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $3,404.00 General
08/30/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $10,892.40 General
08/05/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $13,616.00 General
07/28/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. Food and Beverage In-kind items and services $154.29 General
06/29/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $17,020.00 General
06/03/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $13,616.00 General
04/29/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $13,616.00 General

About Dr. Ryan Lang, M.D

Dr. Ryan Lang, M.D is a Internal Medicine healthcare provider based in Princeton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2013. The National Provider Identifier (NPI) number assigned to this provider is 1366785818.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Lang, M.D has received a total of $443,150 in payments from pharmaceutical and medical device companies, with $204,238 received in 2022. These payments were reported across 33 transactions from 1 company. The most common payment nature is "Consulting Fee" ($442,970).

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Public Health & General Preventive Medicine
  • Location Princeton, NJ
  • Active Since 04/03/2013
  • Last Updated 08/16/2021
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1366785818

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Princeton